Macrophages, Meta-Inflammation, and Immuno-Metabolism

Current research depicts specific modes of immunity and energy metabolism as being interrelated at the molecular, cellular, organ and organism level. Hence, whereas M2 (alternatively-activated) macrophages dominate insulin-sensitive adipose tissue in the lean, M1-skewed (classically-activated) macrophages accumulate in parallel to adiposity in the obese, and promote inflammation and insulin resistance, that is, meta-inflammation. The latest frontier of immuno-metabolism explores the coregulation of energy metabolism and immune function within hematopoietic cells. M1-skewed macrophages are sustained in edematous, hypoxic tissues by anaerobic glycolysis, whereas mitochondrial biogenesis and respiration dominates in M2 cells. We review the underlying mechanisms and the consequences of the transition from M2 to M1 predominance in adipose tissue, as well as the extracellular signals and transcription factors that control macrophage phenotypes and impose distinct metabolic modes.

[1]  T. Asano,et al.  Adipocyte-macrophage interaction may mediate LPS-induced low-grade inflammation: Potential link with metabolic complications , 2012, Innate immunity.

[2]  V. Arroyo,et al.  Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype , 2011, The Journal of Immunology.

[3]  J. Mauer,et al.  Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans , 2011, International Journal of Obesity.

[4]  D. Leroith,et al.  The metabolic syndrome--from insulin resistance to obesity and diabetes. , 2011, The Medical clinics of North America.

[5]  J. Clària,et al.  New Insights into the Role of Macrophages in Adipose Tissue Inflammation and Fatty Liver Disease: Modulation by Endogenous Omega-3 Fatty Acid-Derived Lipid Mediators , 2011, Front. Immun..

[6]  P. Ingham,et al.  Activation of hypoxia-inducible factor-1α (Hif-1α) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model. , 2011, Blood.

[7]  C. Lumeng,et al.  Adipose tissue macrophages: phenotypic plasticity and diversity in lean and obese states , 2011, Current opinion in clinical nutrition and metabolic care.

[8]  Yunan Tang,et al.  Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese‐diabetic mice , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  R. Locksley,et al.  Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.

[10]  Mahboob Rahman,et al.  Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: Risk reduction in a chronic inflammatory disease , 2011, Arthritis care & research.

[11]  M. Febbraio,et al.  Hematopoietic Cell–Restricted Deletion of CD36 Reduces High-Fat Diet–Induced Macrophage Infiltration and Improves Insulin Signaling in Adipose Tissue , 2011, Diabetes.

[12]  P. Mandal,et al.  Molecular Mechanism for Adiponectin-dependent M2 Macrophage Polarization , 2011, The Journal of Biological Chemistry.

[13]  David Montaner,et al.  Differential Lipid Partitioning Between Adipocytes and Tissue Macrophages Modulates Macrophage Lipotoxicity and M2/M1 Polarization in Obese Mice , 2011, Diabetes.

[14]  C. Serhan,et al.  Saturated‐efferocytosis generates pro‐resolving CD11blow macrophages: Modulation by resolvins and glucocorticoids , 2011, European journal of immunology.

[15]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[16]  A. Chawla,et al.  Alternative macrophage activation and metabolism. , 2011, Annual review of pathology.

[17]  D. Mathis,et al.  Immunometabolism: an emerging frontier , 2011, Nature Reviews Immunology.

[18]  Katsuhiko Suzuki,et al.  Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. , 2010, Exercise immunology review.

[19]  R. Evans,et al.  STAT6 Transcription Factor Is a Facilitator of the Nuclear Receptor PPARγ-Regulated Gene Expression in Macrophages and Dendritic Cells , 2010, Immunity.

[20]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[21]  A. Chawla,et al.  In obesity and weight loss, all roads lead to the mighty macrophage. , 2010, The Journal of clinical investigation.

[22]  R. Zechner,et al.  Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. , 2010, The Journal of clinical investigation.

[23]  R. Taguchi,et al.  Transgenic Restoration of Long-Chain n-3 Fatty Acids in Insulin Target Tissues Improves Resolution Capacity and Alleviates Obesity-Linked Inflammation and Insulin Resistance in High-Fat–Fed Mice , 2010, Diabetes.

[24]  N. Larsen,et al.  Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects , 2010, British Journal of Nutrition.

[25]  S. Watkins,et al.  GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects , 2010, Cell.

[26]  M. Al-Omran,et al.  Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages. , 2010, American journal of physiology. Heart and circulatory physiology.

[27]  D. Payen,et al.  Bench-to-bedside review: Glucose and stress conditions in the intensive care unit , 2010, Critical care.

[28]  Daniel Rico,et al.  Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation , 2010, The Journal of Immunology.

[29]  K. Petersen,et al.  Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.

[30]  A. Chawla Control of macrophage activation and function by PPARs. , 2010, Circulation research.

[31]  J. Clària,et al.  Resolution of Adipose Tissue Inflammation , 2010, TheScientificWorldJournal.

[32]  B. Gustafson Adipose tissue, inflammation and atherosclerosis. , 2010, Journal of atherosclerosis and thrombosis.

[33]  Dorothy D. Sears,et al.  Functional Heterogeneity of CD11c-positive Adipose Tissue Macrophages in Diet-induced Obese Mice* , 2010, The Journal of Biological Chemistry.

[34]  G. Hotamisligil,et al.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[35]  Robert V Farese,et al.  DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation. , 2010, The Journal of clinical investigation.

[36]  A. Vidal-Puig,et al.  Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome--an allostatic perspective. , 2010, Biochimica et biophysica acta.

[37]  K. Strissel,et al.  Dynamic, M2-Like Remodeling Phenotypes of CD11c+ Adipose Tissue Macrophages During High-Fat Diet–Induced Obesity in Mice , 2010, Diabetes.

[38]  Wolfgang Meissner,et al.  15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor β/δ Agonist , 2010, Molecular Pharmacology.

[39]  C. Serhan,et al.  Resolvin D1 binds human phagocytes with evidence for proresolving receptors , 2010, Proceedings of the National Academy of Sciences.

[40]  K. Walsh,et al.  Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory Phenotype* , 2009, The Journal of Biological Chemistry.

[41]  Tsutomu Takeuchi,et al.  Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells , 2009, Nature.

[42]  I. Verma,et al.  Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. , 2009, Cell metabolism.

[43]  M. Reilly,et al.  Experimental Endotoxemia Induces Adipose Inflammation and Insulin Resistance in Humans , 2009, Diabetes.

[44]  Lawrence Steinman,et al.  PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance , 2009, Nature Medicine.

[45]  J. Fernández-Real,et al.  Increase in Plasma Endotoxin Concentrations and the Expression of Toll-Like Receptors and Suppressor of Cytokine Signaling-3 in Mononuclear Cells After a High-Fat, High-Carbohydrate Meal , 2009, Diabetes Care.

[46]  V. Nizet,et al.  Interdependence of hypoxic and innate immune responses , 2009, Nature Reviews Immunology.

[47]  G. Natoli,et al.  Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Isao Usui,et al.  Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice , 2009, Diabetes.

[49]  T. Kadowaki,et al.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity , 2009, Nature Medicine.

[50]  K. Clément,et al.  Deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice , 2009, Nature Medicine.

[51]  V. Arroyo,et al.  Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  M. Blüher,et al.  Adipose tissue dysfunction in obesity. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[53]  Ralph A. DeFronzo,et al.  From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus , 2009, Diabetes.

[54]  S. Gordon,et al.  Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.

[55]  A. Lombardi,et al.  From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[56]  Y. Hirata,et al.  Role of CC Chemokine Receptor 2 in Bone Marrow Cells in the Recruitment of Macrophages into Obese Adipose Tissue* , 2008, Journal of Biological Chemistry.

[57]  M. Toner,et al.  Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution1 , 2008, The Journal of Immunology.

[58]  A. Saltiel,et al.  Phenotypic Switching of Adipose Tissue Macrophages With Obesity Is Generated by Spatiotemporal Differences in Macrophage Subtypes , 2008, Diabetes.

[59]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[60]  Haiyan Xu,et al.  Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes , 2008, Diabetes.

[61]  D. Gilroy,et al.  Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP , 2008, Blood.

[62]  P. Libby,et al.  Interferon- (cid:1) , a Th1 Cytokine, Regulates Fat Inflammation A Role for Adaptive Immunity in Obesity , 2022 .

[63]  V. Hombach,et al.  T-lymphocyte Infiltration in Visceral Adipose Tissue: A Primary Event in Adipose Tissue Inflammation and the Development of Obesity-Mediated Insulin Resistance , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[64]  Tom Britton,et al.  Dynamics of fat cell turnover in humans , 2008, Nature.

[65]  Katerina Akassoglou,et al.  NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α , 2008, Nature.

[66]  Chih-Hao Lee,et al.  Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. , 2008, Cell metabolism.

[67]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[68]  F. Karpe,et al.  Remodeling Phenotype of Human Subcutaneous Adipose Tissue Macrophages , 2008, Circulation.

[69]  P. Havel,et al.  Effect of dietary n-3 polyunsaturated fatty acids on plasma total and high-molecular-weight adiponectin concentrations in overweight to moderately obese men and women. , 2008, The American journal of clinical nutrition.

[70]  T. Kadowaki,et al.  In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. , 2008, The Journal of clinical investigation.

[71]  F. Chehab Obesity and lipodystrophy--where do the circles intersect? , 2008, Endocrinology.

[72]  X. Zhang,et al.  Macrophage activation by endogenous danger signals , 2008, The Journal of pathology.

[73]  C. Glass,et al.  A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-like Receptors 2 and 4 and JNK-dependent Pathways* , 2007, Journal of Biological Chemistry.

[74]  M. Karin,et al.  JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. , 2007, Cell metabolism.

[75]  T. Stulnig,et al.  Adipose tissue macrophages. , 2007, Immunology letters.

[76]  C. Knauf,et al.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia , 2007, Diabetologia.

[77]  Y. Kamei,et al.  Increased Adiponectin Secretion by Highly Purified Eicosapentaenoic Acid in Rodent Models of Obesity and Human Obese Subjects , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[78]  J. Carvalheira,et al.  Loss-of-Function Mutation in Toll-Like Receptor 4 Prevents Diet-Induced Obesity and Insulin Resistance , 2007, Diabetes.

[79]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[80]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[81]  C. Glass,et al.  Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. , 2007, The Journal of clinical investigation.

[82]  C. Serhan,et al.  Resolvins and protectins in the termination program of acute inflammation. , 2007, Trends in immunology.

[83]  S Kumar,et al.  Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. , 2007, American journal of physiology. Endocrinology and metabolism.

[84]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[85]  A. Saltiel,et al.  Increased Inflammatory Properties of Adipose Tissue Macrophages Recruited During Diet-Induced Obesity , 2007, Diabetes.

[86]  W. Schiemann,et al.  Apoptotic Cells, through Transforming Growth Factor-β, Coordinately Induce Anti-inflammatory and Suppress Pro-inflammatory Eicosanoid and NO Synthesis in Murine Macrophages* , 2006, Journal of Biological Chemistry.

[87]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[88]  V. Arroyo,et al.  Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S‐hydroxy‐DHA , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[89]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[90]  S. Jebb,et al.  Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women , 2006, International Journal of Obesity.

[91]  D. Greaves,et al.  Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. , 2006, Cell metabolism.

[92]  G. Semenza,et al.  Activation of hypoxia-inducible factor 1 during macrophage differentiation. , 2006, American journal of physiology. Cell physiology.

[93]  D. Hwang,et al.  The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. , 2006, Molecules and cells.

[94]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[95]  C. Serhan,et al.  The Docosatriene Protectin D1 Is Produced by TH2 Skewing and Promotes Human T Cell Apoptosis via Lipid Raft Clustering* , 2005, Journal of Biological Chemistry.

[96]  Shupei Wang,et al.  Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Published, JLR Papers in Press, September 8, 2005. DOI 10.1194/jlr.M500294-JLR200 , 2005, Journal of Lipid Research.

[97]  T. Suganami,et al.  A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[98]  T. Olsson,et al.  0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(10):5834–5840 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2005-0369 A Unique Role of Monocyte Chemoattractant Protein 1 among Chemokines in Adipose , 2022 .

[99]  Amir Gamliel,et al.  A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ , 2005, Nature.

[100]  Jean-Daniel Zucker,et al.  Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. , 2005, Diabetes.

[101]  V. Nizet,et al.  HIF-1alpha expression regulates the bactericidal capacity of phagocytes. , 2005, The Journal of clinical investigation.

[102]  Charles N. Serhan,et al.  Molecular circuits of resolution: formation and actions of resolvins and protectins , 2005, The Journal of Immunology.

[103]  S. B. Pedersen,et al.  Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. , 2005, The Journal of clinical endocrinology and metabolism.

[104]  A. Hevener,et al.  IKK-β links inflammation to obesity-induced insulin resistance , 2005, Nature Medicine.

[105]  Y. Zick,et al.  Ser/Thr Phosphorylation of IRS Proteins: A Molecular Basis for Insulin Resistance , 2005, Science's STKE.

[106]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[107]  D. Accili,et al.  Increased CD36 protein as a response to defective insulin signaling in macrophages. , 2004, The Journal of clinical investigation.

[108]  N. Sizemore,et al.  Reciprocal Modulation of Toll-like Receptor-4 Signaling Pathways Involving MyD88 and Phosphatidylinositol 3-Kinase/AKT by Saturated and Polyunsaturated Fatty Acids* , 2003, Journal of Biological Chemistry.

[109]  J. Holst,et al.  Insulin secretion and cellular glucose metabolism after prolonged low-grade intralipid infusion in young men. , 2003, The Journal of clinical endocrinology and metabolism.

[110]  R. Jaenisch,et al.  HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation , 2003, Cell.

[111]  Carl Nathan,et al.  Points of control in inflammation , 2002, Nature.

[112]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[113]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[114]  R. Little,et al.  Insulin resistance and substrate utilization in human endotoxemia. , 2000, The Journal of clinical endocrinology and metabolism.

[115]  T. Willson,et al.  Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase , 1999, Nature.

[116]  J. Ihle,et al.  Interleukin-4 and -13 induce upregulation of the murine macrophage 12/15-lipoxygenase activity: evidence for the involvement of transcription factor STAT6. , 1998, Blood.

[117]  J. Morrow,et al.  Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. , 1994, The Journal of biological chemistry.

[118]  J. Drazen,et al.  Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. , 1993, The Journal of clinical investigation.

[119]  H. Rasmussen,et al.  Physiology and Pathophysiology of Insulin Secretion , 1990, Diabetes Care.

[120]  C. Nathan,et al.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.

[121]  M. Birnbaum,et al.  Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin , 2011, Nature Medicine.

[122]  M. Ruth Normalization of obesity-associated insulin resistance through immunotherapy , 2010 .

[123]  茂呂 和世 Innate production of T[H]2 cytokines by adipose tissue-associated c-Kit[+]Sca-1[+] lymphoid cells , 2010 .

[124]  J. Bassaganya-Riera,et al.  PPAR γ is highly expressed in F 4 / 80 hi adipose tissue macrophages and dampens adipose-tissue inflammation , 2009 .

[125]  Masahito Watanabe,et al.  IN MICE , 2009 .

[126]  S. Grey,et al.  Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. , 2007, Endocrinology.

[127]  J. Fernández-Real,et al.  Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. , 2006, Diabetes.

[128]  Samuel I. Miller,et al.  LPS, TLR4 and infectious disease diversity , 2005, Nature Reviews Microbiology.

[129]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.